Evaluation of radixact motion synchrony for 3D respiratory motion: Modeling accuracy and dosimetric fidelity

The Radixact® linear accelerator contains the motion Synchrony system, which tracks and compensates for intrafraction patient motion. For respiratory motion, the system models the motion of the target and synchronizes the delivery of radiation with this motion using the jaws and multi‐leaf collimato...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied clinical medical physics 2020-09, Vol.21 (9), p.96-106
Hauptverfasser: Ferris, William S., Kissick, Michael W., Bayouth, John E., Culberson, Wesley S., Smilowitz, Jennifer B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Radixact® linear accelerator contains the motion Synchrony system, which tracks and compensates for intrafraction patient motion. For respiratory motion, the system models the motion of the target and synchronizes the delivery of radiation with this motion using the jaws and multi‐leaf collimators (MLCs). It was the purpose of this work to determine the ability of the Synchrony system to track and compensate for different phantom motions using a delivery quality assurance (DQA) workflow. Thirteen helical plans were created on static datasets from liver, lung, and pancreas subjects. Dose distributions were measured using a Delta4® Phantom+ mounted on a Hexamotion® stage for the following three case scenarios for each plan: (a) no phantom motion and no Synchrony (M0S0), (b) phantom motion and no Synchrony (M1S0), and (c) phantom motion with Synchrony (M1S1). The LEDs were placed on the Phantom+ for the 13 patient cases and were placed on a separate one‐dimensional surrogate stage for additional studies to investigate the effect of separate target and surrogate motion. The root‐mean‐square (RMS) error between the Synchrony‐modeled positions and the programmed phantom positions was  90%. Only two of the M1S0 measured doses had gamma pass rates > 90%. Motion Synchrony offers a potential alternative to the current, ITV‐based motion management strategy for helical tomotherapy deliveries.
ISSN:1526-9914
1526-9914
DOI:10.1002/acm2.12978